Business Description
Chosa Oncology AB
ISIN : SE0007784319
Compare
Compare
Traded in other countries / regions
CHOSA.SwedenW5L.Germany IPO Date
2016-03-09Description
Chosa Oncology AB is a biotechnology company engaged in the research and development in immunotherapy on therapeutic cancer vaccines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.86 | |||||
| Piotroski F-Score | 5/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 9 | |||||
| 3-Year EPS without NRI Growth Rate | 0.7 | |||||
| 3-Year FCF Growth Rate | 19.2 | |||||
| 3-Year Book Growth Rate | -59.6 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.31 | |||||
| 9-Day RSI | 54.75 | |||||
| 14-Day RSI | 56.8 | |||||
| 6-1 Month Momentum % | 53.13 | |||||
| 12-1 Month Momentum % | -20.47 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.71 | |||||
| Quick Ratio | 3.71 | |||||
| Cash Ratio | 0.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -54.79 | |||||
| ROA % | -33.28 | |||||
| ROIC % | -43.8 | |||||
| ROC (Joel Greenblatt) % | -190.54 | |||||
| ROCE % | -47.32 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 3.26 | |||||
| Price-to-Tangible-Book | 7.13 | |||||
| Price-to-Free-Cash-Flow | 4.25 | |||||
| Price-to-Operating-Cash-Flow | 4.25 | |||||
| EV-to-EBIT | -6.78 | |||||
| EV-to-EBITDA | -6.78 | |||||
| EV-to-Forward-EBITDA | -0.04 | |||||
| EV-to-Forward-Revenue | 0.29 | |||||
| EV-to-FCF | 15.01 | |||||
| Price-to-Net-Current-Asset-Value | 7.13 | |||||
| Earnings Yield (Greenblatt) % | -14.75 | |||||
| FCF Yield % | 6.54 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chosa Oncology AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.484 | ||
| Beta | 0 | ||
| Volatility % | 126.08 | ||
| 14-Day RSI | 56.8 | ||
| 14-Day ATR (kr) | 0.139695 | ||
| 20-Day SMA (kr) | 1.0068 | ||
| 12-1 Month Momentum % | -20.47 | ||
| 52-Week Range (kr) | 0.3 - 2.25 | ||
| Shares Outstanding (Mil) | 64.87 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chosa Oncology AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chosa Oncology AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chosa Oncology AB Frequently Asked Questions
What is Chosa Oncology AB(XSAT:CHOSA)'s stock price today?
The current price of XSAT:CHOSA is kr1.00. The 52 week high of XSAT:CHOSA is kr2.25 and 52 week low is kr0.30.
When is next earnings date of Chosa Oncology AB(XSAT:CHOSA)?
The next earnings date of Chosa Oncology AB(XSAT:CHOSA) is 2024-05-10.
Does Chosa Oncology AB(XSAT:CHOSA) pay dividends? If so, how much?
Chosa Oncology AB(XSAT:CHOSA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers